Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07VWT
|
||||
Former ID |
DIB003680
|
||||
Drug Name |
Platelet activating factor receptor inhibitors
|
||||
Synonyms |
Platelet activating factor receptor inhibitors (pain); Platelet activating factor receptor inhibitors (pain), Merck & Co
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Investigative | [1] | ||
Company |
Merck & Co Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
FC(F)(c1cc(C(F)(F)F)cc(c2ccc(cc2)C(=O)N2CCC(C2)c2cnccc2<br />)c1)F
|
||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Inhibitor | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad Sci U S A. 1985 Feb;82(3):672-6. | ||||
REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 334). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.